State Medicaid DUR Board Meeting
General Information
- Government Type
- State Agency
- Entity
- Department of Health and Human Services (DHHS)
- Public Body
- Drug Utilization Review Board
Notice Information
- Notice Title
- State Medicaid DUR Board Meeting
- Notice Tags
- Medicaid, Health Care
- Notice Type(s)
- Meeting, Hearing
- Event Start Date & Time
- May 8, 2025 07:15 AM
- Event End Date & Time
- May 8, 2025 08:30 AM
- Event Deadline Date & Time
- 05/08/25 08:30 AM
- Description/Agenda
- Drug Utilization Review Board Meeting Agenda Thursday, May 8, 2025 7:15 a.m. to 8:30 a.m. Google Meet joining info Video call link: meet.google.com/zue-rrqz-rpb Or dial: (US) +1 904-900-0180 PIN: 172 873 306# Persons who wish to address the DUR Board may contact Luis Moreno at lmoreno@utah.gov prior to the meeting, or sign up to provide comments at the meeting. Public comments will be limited to 3 minutes per speaker or organization due to time constraints. 1) Call to order - Sharon Weinstein, MD a) Welcome and Introductions b) Review and Approval of Minutes 2) P&T Committee Update - Ngan Huynh, PharmD 3) Review a) Alhemo (concizumab-mtci) DRRC Presentation - Monet Luloh, PharmD i) Committee Discussion/Questions b) Qfitlia (fitusiran) Presentation - Luis Moreno, PharmD i) Committee Discussion/Questions c) Public Comment i) Sanofi: Qfitglia - Thu-Mai Duong, PharmD ii) Biogen: Skyclarys - Lynda Finch, PhD iii) Friedereich's Ataxia Research Alliance - Kellyn Madden, MS, CGC iv) Eli Lilly: Zepbound - Beth Lubelcyzk, PharmD v) Johnson & Johnson: Spravato - Amy Hale, PharmD d) Alhemo (concizumab-mtci) Prior Authorization - Ngan Huynh, PharmD i) Committee Discussion/Questions ii) Committee Action e) Qfitlia (fitusiran) Prior Authorization - Luis Moreno, PharmD i) Committee Discussion/Questions ii) Committee Action f) Skyclarys (omaveloxolone) Prior Authorization - Luis Moreno, PharmD i) Committee Discussion/Questions ii) Committee Action g) Zepbound (tirzepatide) Prior Authorization - Kyu Yun Park, PharmD i) Committee/Discussion/Questions ii) Committee Action h) Spravato (esketamine) Prior Authorization - Iris Wan, PharmD i) Committee/Discussion/Questions ii) Committee Action 4) Next Meeting a) June 12, 2025 - Open Public Meeting Annual Training, review of Tryvio (aprocitentan) as adjunct for hypertension, Zynteglo (betibeglogene autotemcel), and GLP-1 Medications for Weight Loss prior authorization forms. 5) Adjourned - Sharon Weinstein, MD
- Notice of Special Accommodations (ADA)
- In compliance with the Americans with Disabilities Act, individuals needing special accommodations (including auxiliary communicative aids and services) during this meeting should notify Luis Moreno at 801-538-6155.
- Notice of Electronic or Telephone Participation
- Video call link: meet.google.com/zue-rrqz-rpb Or dial: (US) +1 904-900-0180 PIN: 172 873 306#
Meeting Information
- Meeting Location
-
Video/Teleconferencing
Video/Teleconferencing, UT 84116
Show in Apple Maps Show in Google Maps - Contact Name
- Luis Moreno
- Contact Email
- lmoreno@utah.gov
- Contact Phone
- 801-538-6155
Notice Posting Details
- Notice Posted On
- April 24, 2025 04:34 PM
- Notice Last Edited On
- May 07, 2025 10:02 AM
- Deadline Date
- May 8, 2025 08:30 AM
Notice Revision History
| Revision Number | Notice Edited On | Edited By |
|---|---|---|
| 5 | May 7, 2025 10:02 AM | cdevashrayee@utah.gov |
| 4 | May 7, 2025 09:56 AM | cdevashrayee@utah.gov |
| 3 | May 6, 2025 11:13 PM | cdevashrayee@utah.gov |
| 2 | April 24, 2025 04:50 PM | cdevashrayee@utah.gov |
| 1 | April 24, 2025 04:45 PM | cdevashrayee@utah.gov |
Subscribe
Subscribe by Email
Subscription options will send you alerts regarding future notices posted by this Body.